Search for Clinical Trial Results
Paraparesis, Tropical Spastic - 19 Studies Found
Status | Study |
Completed |
Study Name: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial Condition: HTLV-I-associated Myelopathy Date: 2006-01-04 Interventions: Drug: Zidovudine/lamivudine |
Completed |
Study Name: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV-I-Associated Myelopathy Date: 2011-04-25 Interventions: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Study Name: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis Condition: Tropical Spastic Paraparesis Date: 2002-05-01 |
Completed |
Study Name: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV I Associated Myelopathy Date: 2008-10-15 Interventions: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Not yet recruiting |
Study Name: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Condition:
Date: 2015-11-16 Interventions: Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Completed |
Study Name: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) Condition:
|
Terminated |
Study Name: The HAM Infliximab Study Condition: HTLV-I-associated Myelopathy Date: 2009-01-14 Interventions: Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Terminated |
Study Name: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condition: HTLV-I-Associated Myelopathy Date: 2007-08-20 Interventions: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
Study Name: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Condition: HTLV-I Date: 2006-06-19 |
Recruiting |
Study Name: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condition: HTLV-1 Date: 2006-07-12 Interventions: Drug: Hu MiK-Beta-1 |